Phase
Condition
Urothelial Tract Cancer
Renal Cell Cancer
Urologic Cancer
Treatment
Ropivacaine HCL
ropivacaine + epineprine + clonidine + ketoralac
Epinephrine
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ability to understand and willingness to sign an IRB-approved informed consent
Age ≥ 18 years at the time of consent.
Planned robotic partial or radical nephrectomy
Exclusion
Exclusion Criteria:
Determined not to be a candidate to receive R.E.C.K or Exparel per the enrollinginvestigator
Known pregnancy
Chronic opioid use within 30 days (as per patient report) prior to randomization (defined as ≥ 30 MME/day)
Uncontrolled intercurrent illness including, but not limited to, ongoing or activeinfection, symptomatic congestive heart failure, unstable angina pectoris, cardiacarrhythmia, or psychiatric illness/social situations that would limit compliancewith study requirements as determined by the investigator.
Known allergy to R.E.C.K. and/or Exparel
Study Design
Study Description
Connect with a study center
Levine Cancer
Charlotte, North Carolina 28204
United StatesSite Not Available
Levine Cancer
Charlotte 4460243, North Carolina 4482348 28204
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.